Erlotinib Tablets are a medicine used in the treatment of certain types of cancer, particularly those driven by abnormal activity of the epidermal growth factor receptor (EGFR). They belong to a class of drugs called tyrosine kinase inhibitors (TKIs).

Here are the key details:

• Composition: Each tablet contains Erlotinib hydrochloride as the active ingredient, commonly in strengths such as 25 mg, 100 mg, or 150 mg.

• Dosage Form: Oral tablets, usually taken once daily on an empty stomach or as prescribed by a doctor.

• Mode of Action:

  • Erlotinib selectively inhibits the EGFR tyrosine kinase, a protein that promotes cancer cell growth and survival.

  • By blocking this receptor, it slows tumor growth and can trigger cancer cell death.

• Uses:

  • Non-small cell lung cancer (NSCLC) with EGFR mutations.

  • Pancreatic cancer (usually in combination with chemotherapy).

• Treatment Goal: To slow cancer progression, reduce tumor size, and improve patient survival in cancers sensitive to EGFR inhibition.

• Side Effects:

  • Common: rash, diarrhea, loss of appetite, fatigue, nausea, vomiting.

  • Serious: liver toxicity, interstitial lung disease, severe skin reactions, eye problems.

• Precautions:

  • Liver function and skin condition should be monitored regularly.

  • Should be taken carefully with medications that affect stomach acidity or liver enzymes, as they can alter absorption and effectiveness.

  • Not recommended during pregnancy or breastfeeding.

  • Avoid self-medicating; must be used under oncology supervision.

👉 Erlotinib is a targeted therapy that works on cancers with specific molecular features, offering a more focused treatment compared to traditional chemotherapy.